The company expired its plan on October 26, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.13 CNY | -0.19% | +5.52% | -14.31% |
26/04 | BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
15/04 | BGI Genomics Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.31% | 2.16B | |
-19.78% | 10.91B | |
+44.90% | 3.3B | |
-33.46% | 2.19B | |
-28.86% | 1.5B | |
+25.34% | 1.09B | |
-3.28% | 737M | |
-35.33% | 404M | |
-46.53% | 386M | |
+17.30% | 342M |
- Stock Market
- Equities
- 300676 Stock
- News BGI Genomics Co., Ltd.
- BGI Genomics Co., Ltd.'s Equity Buyback announced on October 27, 2021, has expired.